Literature DB >> 16784783

Human papillomavirus type 16 variant assignment by pyrosequencing.

David C Swan1, Josef R Limor, Kara L Duncan, Mangalathu S Rajeevan, Elizabeth R Unger.   

Abstract

Polymorphisms in human papillomavirus type 16 (HPV16) result in variants from the prototype sequence which can be designated according to geographic distribution and are broadly classified as European (E), African (Af), Asian (As), or Asian-American (AA). Detection of variants has been used to distinguish persistent HPV16 infection from re-infection in natural history studies, and variants have been associated with an increased risk of cervical disease in some populations. Variant determination usually relies on conventional Sanger sequencing of regions of the viral genome, with the major variant group assignments requiring the sequencing of only seven polymorphic sites spread over a 242-bp region of the E6 gene. We applied pyrosequencing to facilitate rapid sequencing and enable the simultaneous detection of multiple variants. A single-stranded template for pyrosequencing was prepared by amplifying a 314-bp fragment (nt 75-388) with a biotin at the 5'-end of the reverse primer to facilitate strand separation and purification. Polymorphisms at the nucleotide sites 109, 131, 132, 143, 145, 178 and 350 were determined in three separate sequencing reactions, one of which was a multiplex format. Pyrosequencing of 97 HPV16-positive exfoliated cervical samples confirmed the Sanger sequencing results; however pyrosequencing identified additional variants in several samples containing mixed variants.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784783     DOI: 10.1016/j.jviromet.2006.05.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction.

Authors:  Martin Steinau; Elizabeth R Unger; Brenda Y Hernandez; Marc T Goodman; Glenn Copeland; Claudia Hopenhayn; Wendy Cozen; Maria S Saber; Youjie Huang; Edward S Peters; Charles F Lynch; Edward J Wilkinson; Mangalathu S Rajeevan; Christopher Lyu; Mona Saraiya
Journal:  J Low Genit Tract Dis       Date:  2013-10       Impact factor: 1.925

2.  HPV16 viral characteristics in primary, recurrent and metastatic vulvar carcinoma.

Authors:  Gabriella Lillsunde Larsson; Malin Kaliff; Bengt Sorbe; Gisela Helenius; Mats G Karlsson
Journal:  Papillomavirus Res       Date:  2018-11-02

3.  Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection.

Authors:  Michael Cullen; Joseph F Boland; Mark Schiffman; Xijun Zhang; Nicolas Wentzensen; Qi Yang; Zigui Chen; Kai Yu; Jason Mitchell; David Roberson; Sara Bass; Laurie Burdette; Moara Machado; Sarangan Ravichandran; Brian Luke; Mitchell J Machiela; Mark Andersen; Matt Osentoski; Michael Laptewicz; Sholom Wacholder; Ashlie Feldman; Tina Raine-Bennett; Thomas Lorey; Philip E Castle; Meredith Yeager; Robert D Burk; Lisa Mirabello
Journal:  Papillomavirus Res       Date:  2015-12-01

4.  Long-term follow-up of HPV16-positive women: persistence of the same genetic variant and low prevalence of variant co-infections.

Authors:  Daan T Geraets; Leen-Jan van Doorn; Bernhard Kleter; Brigitte Colau; Diane M Harper; Wim G V Quint
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

5.  Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy.

Authors:  Malin Kaliff; Bengt Sorbe; Louise Bohr Mordhorst; Gisela Helenius; Mats G Karlsson; Gabriella Lillsunde-Larsson
Journal:  Oncotarget       Date:  2018-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.